Medicine to Market Summit (@market_summit) header
Medicine to Market Summit (@market_summit) profile picture

Medicine to Market is the leading source of life science news and best practices powered by peer-generated insights.

Joined September 2021
Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)Photo by Medicine to Market Summit (@market_summit)
Learn how smaller firms use RAG (Retrieval-Augmented Generation) and "Small Data" to build secure, proprietary AI engines without leaking IP or breaking the bank. lttr.ai/AoPAa
9
$crnx @Crinetics label review of paltusotine. This will not be an easy sell with dosing and monitoring recommendations.
1
665
We can create, preview, schedule, and analyze all social media posts using Publer. 🦸‍♂️ The intuitive dashboard allows me to curate posts in detail & collaborate smoothly with the entire workspace. Try it today for FREE! publer.com/arsenal via @publer
1
54
What does the rest of 2025 have in store for biotech- let's find out lttr.ai/AfEXp
25
Summit Therapeutics’ Ivonescimab Shows Promise in Phase III Lung Cancer Trial Despite Mixed Results lttr.ai/AfD02
109
Just got my weather update and the latest breaking pharma/biotech news recapped in a NYT style. Proxy made it a breeze to stay informed and productive. #proxy proxy.convergence.ai
21
Unlocking Innovation: Break Free from the Castle Walls!
14
Unlocking Innovation: Industry Collaboration for a Better Future
8
Understood. I will provide an SEO-optimized title for the given content without any additional commentary. Please provide the current title and content for inspiration. See the story at medicinetomarket.com/underst…
8
Biotech Layoffs: Navigating Legal Risks During Restructuring See the story at medicinetomarket.com/biotech…
11
Eli Lilly's Tirzepatide: Outpacing Novo Nordisk in Weight-Loss Race? See the story at medicinetomarket.com/eli-lil…
26
Reauthorize FDA's Priority Review Voucher Program for Pediatric Rare Diseases See the story at medicinetomarket.com/reautho…
9
Leqembi Approved for Alzheimer's Treatment in Israel, Eisai Announces See the story at medicinetomarket.com/leqembi…
39
Mirum Grants Stock Options and RSUs to New Employees - July 2024 See the story at medicinetomarket.com/mirum-g…
11
Top 10 Tips to Harness AI's Power in Biotech Drug Development See the story at medicinetomarket.com/top-10-…
6
Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment See the story at medicinetomarket.com/mesobla…
19